胰淀素可能是2型糖尿病与阿尔茨海默病之间的潜在联系
研究比较了87例阿尔茨海默病(AD)患者与48例无神经病理改变者的胰腺和脑组织,检测胰腺中β-淀粉样蛋白(Aβ)与tau沉积以及脑中胰淀素沉积。结果显示AD患者胰腺β细胞存在tau和Aβ胞质沉积,脑内可见胰淀素沉积,且胰淀素可与Aβ及tau相互作用,提示2型糖尿病(T2DM)与AD致病机制可能存在重叠。
要点
- AD患者胰腺β细胞可见tau和Aβ胞质沉积。
- AD患者脑内可检出胰淀素沉积。
- 胰淀素可在胰腺与海马中与Aβ及tau相互作用。
核心结论
- 胰腺β细胞同时存在tau和Aβ包涵体、脑内存在胰淀素沉积,为T2DM与AD致病机制潜在重叠提供了新证据。
研究设计与样本
- 研究纳入87例诊断为AD的受试者与48例无神经病理改变的个体,检查胰腺与脑组织中Aβ、tau及胰淀素的沉积,并用邻位连接法检测tau/Aβ与胰淀素的相互作用。
主要发现
- AD受试者胰腺β细胞检出胞质tau和Aβ蛋白沉积。
- 有T2DM病史但神经病理检查正常者及一小队列无T2DM对照者亦可见上述胰腺沉积。
- 上述受试者脑内检出胰淀素沉积,组织学证据显示胰淀素可在胰腺和海马与Aβ及tau相互作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Alzheimer disease (AD) is the leading cause of dementia, and although its etiology remains unclear, it seems that type 2 diabetes mellitus (T2DM) and other prediabetic states of insulin resistance could contribute to the appearance of sporadic AD. As such, we have assessed whether tau and β-amyloid (Aβ) deposits might be present in pancreatic tissue of subjects with AD, and whether amylin, an amyloidogenic protein deposited in the pancreas of T2DM patients, might accumulate in the brain of AD patients. METHODS: We studied pancreatic and brain tissue from 48 individuals with no neuropathological alterations and from 87 subjects diagnosed with AD. We examined Aβ and tau accumulation in the pancreas as well as that of amylin in the brain. Moreover, we performed proximity ligation assays to ascertain whether tau and/or Aβ interact with amylin in either the pancreas or brain of these subjects. RESULTS: Cytoplasmic tau and Aβ protein deposits were detected in pancreatic β cells of subjects with AD as well as in subjects with a normal neuropathological examination but with a history of T2DM and in a small cohort of control subjects without T2DM. Furthermore, we found amylin deposits in the brain of these subjects, providing histological evidence that amylin can interact with Aβ and tau in both the pancreas and hippocampus. INTERPRETATION: The presence of both tau and Aβ inclusions in pancreatic β cells, and of amylin deposits in the brain, provides new evidence of a potential overlap in the mechanisms underlying the pathogenesis of T2DM and AD. ANN NEUROL 2019;86:539-551.
引用
- Martinez-Valbuena I, Valenti-Azcarate R, Amat-Villegas I, et al. Amylin as a potential link between type 2 diabetes and alzheimer disease. Ann Neurol. 2019. PMID: 31376172. doi:10.1002/ana.25570
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。